Publications by authors named "Mohammed Reza Mizani"
Am J Nephrol
October 2024
Article Synopsis
- Ferric citrate (FC) is a phosphate binder for dialysis patients with chronic kidney disease, and this study examined its effects on the use of erythropoiesis-stimulating agents (ESAs) and IV iron.
- In a study involving over 200 dialysis patients, those treated with FC showed a significant reduction in monthly ESA doses compared to those on standard care, while showing non-significant changes in IV iron doses.
- Patients receiving FC also saw improvements in hemoglobin and other blood measures, and experienced fewer serious adverse events compared to those receiving standard therapy.
